SCHEMBL185515

SCHEMBL185515

Cc1ccc(Nc2ccc(O)c3c2C(=O)c2ccccc2C3=O)c(S(=O)(=O)[O-])c1.[Na+]

nearest known ligand 0.59

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY4 known ✓ P51582 11/20 0.59
P2RY2 known ✓ P41231 8/20 0.59
P2RY12 known ✓ Q9H244 8/20 0.54
P2RY6 known ✓ Q15077 2/20 0.53
P2RY1 known ✓ P47900 2/20 0.53
THRB known ✓ P10828 1/20 0.49
MET P08581 2/20 0.51
CDK2 P24941 1/20 0.50
MEN1 O00255 1/20 0.49
NSD2 O96028 1/20 0.49
ALDH1A1 P00352 1/20 0.49
POLB P06746 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
MAPK1 P28482 1/20 0.49
RECQL P46063 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30311409 1.00 P2RY4 (0.59) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL29354251 1.00 P2RY4 (0.59) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL29350751 0.93 P2RY4 (0.67) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL126076 0.93 P2RY4 (0.67) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL2859796 0.91 P2RY4 (0.47) P2RY4P2RY2P2RY12P2RY6P2RY1
Hydrochloric Acid SCHEMBL30808003 0.91 P2RY4 (0.65) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL29637834 0.88 P2RY4 (0.61) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL15242090 0.88 MEN1 (0.47) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL20143982 0.88 P2RY2 (0.50) P2RY4P2RY2P2RY12P2RY6P2RY1
SCHEMBL30106754 0.88 P2RY4 (0.61) P2RY4P2RY2P2RY12P2RY6P2RY1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3727287-B1 HAIR DYEING PROCESS COMPRISING A STEP OF DYEING WITH HENNA AND/OR INDIGO AND A TREATMENT STEP COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING A BUFFER SYSTEM OREAL (FR) 2024-12-04 EP claimed
EP-3727287-A1 HAIR DYEING PROCESS COMPRISING A STEP OF DYEING WITH HENNA AND/OR INDIGO AND A TREATMENT STEP COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING A BUFFER SYSTEM L'OREAL (FR) 2020-10-28 EP claimed
EP-2930126-B1 Fashionable aerosol dye HENKEL AG & CO KGAA (DE) 2019-10-09 EP claimed
WO-2018115451-A1 COSMETIC COMPOSITION FOR DIRECT DYEING COMPRISING AN AQUEOUS PHASE AND A FATTY PHASE THAT ARE VISUALLY DISTINCT FROM EACH OTHER L'OREAL (FR) 2018-06-28 WO claimed
US-20100021396-A1 TINTING MOUSSE HENKEL AG & CO. KGAA (DE) 2010-01-28 US claimed
EP-0525073-B1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA DU PONT (US) 1994-05-25 EP claimed
US-12291637-B2 Acidic bonding compositions and methods for restoring and color toning lightened hair L'OREAL (FR) 2025-05-06 US disclosed
US-20250108658-A1 INKJET PRINTING PROCESSES FOR TEMPORARY TATTOOS Prism Inks, Inc. (US) 2025-04-03 US disclosed
EP-3727287-B1 HAIR DYEING PROCESS COMPRISING A STEP OF DYEING WITH HENNA AND/OR INDIGO AND A TREATMENT STEP COMPRISING THE APPLICATION OF A COMPOSITION COMPRISING A BUFFER SYSTEM OREAL (FR) 2024-12-04 EP disclosed
CN-118621464-A Electrostatic spinning solution, artificial hair fiber, and preparation method and application thereof 香港理工大学 2024-09-10 CN disclosed
EP-4373460-A1 NEW COSMETIC COMPOSITIONS CONTAINING ALOE VERA JUICE Yodi SAS (FR) 2024-05-29 EP disclosed
US-20240124708-A1 ACIDIC BONDING COMPOSITIONS AND METHODS FOR RESTORING AND COLOR TONING LIGHTENED HAIR L'OREAL (FR) 2024-04-18 US disclosed
CN-117860613-A Direct hair dyeing product containing cationic cassia seed gum and application thereof 卡乐魔发(上海)国际贸易有限公司 2024-04-12 CN disclosed
US-6146429-A DEVELOPER, COUPLER, BEESWAX AND PROTEIN HYDROLYZATES OR AMINO ACIDS WELLA AKTIENGESELLSCHAFT (DE) 2000-11-14 US disclosed
US-6106579-A MIXTURE OF OXOCARBOXYLIC ACID AND REDUCING AGENT WELLA AKTIENGESELLSCHAFT (DE) 2000-08-22 US disclosed
WO-1995029977-A1 COLOURLESS DETERGENT MIXTURES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1995-11-09 WO disclosed
EP-0525073-B1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA DU PONT (US) 1994-05-25 EP disclosed
EP-0525073-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA. DU PONT (US) 1993-02-03 EP disclosed
WO-1991015954-A1 ANTHRAQUINONES AS INHIBITORS OF SULFIDE PRODUCTION FROM SULFATE-REDUCING BACTERIA E.I. DU PONT DE NEMOURS AND COMPANY (US) 1991-10-31 WO disclosed
US-5015263-A Composition for coloring skin and method CLAIROL INCORPORATED (US) 1991-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12291637-B2 Acidic bonding compositions and methods for restoring and color toning lightened hair SHH, TIPRL, SMURF1 P2RY4 2995/4885P2RY2 3364/4885P2RY12 4113/4885
US-20100021396-A1 TINTING MOUSSE KRT18, MSN, MFAP1 P2RY4 3449/4885P2RY2 3968/4885P2RY12 4175/4885
US-20240124708-A1 ACIDIC BONDING COMPOSITIONS AND METHODS FOR RESTORING AND COLOR TONING LIGHTENED HAIR SHH, TIPRL, SMURF1 P2RY4 2995/4885P2RY2 3364/4885P2RY12 4113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.